Breast implants for beauty enhancement continue to be the most common cosmetic surgical procedure in the USA. Some 400,000 women get breast implants in the United States every year. Nearly 300,000 of these are for cosmetic reasons, and the rest are for reconstruction after mastectomies performed to treat or prevent breast cancer.
However, breast implants are not meant to be lifetime devices
The Food and Drug Administration (FDA) has warned that women with breast implants have a higher chance of squamous cell carcinoma (SCC) and other lymphomas in the tissue around breast implants. Lymphoma is a cancer of the immune system.
Even though lymphomas and other cancers around the implant are rare. But FDA has warned that women with breast implants filled with saline or silicone should get frequent check-ups to ensure that prosthetics are in good condition.
The precise nature of the relationship between breast implants and cancer is not yet clear
The FDA said it was not recommending women remove breast implants. It is advising women to monitor their implants for any abnormal changes. According to a study, less than six percent of patients do this.
Breast implants have been linked to various chronic medical conditions, including swelling, pain, lumps, sensitivity, or asymmetry.
